Overview

To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Status:
Recruiting

Trial end date:
2022-06-30

Target enrollment:

Participant gender:

Summary

To compare the efficacy and safety of Perrigo's product to an FDA approved product in the treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes.

Phase:

Phase 3

Details

Lead Sponsor:

Perrigo Company

Treatments:

Brimonidine Tartrate
Brinzolamide